SPX3,825.33+39.95 1.06%
DIA310.85+3.03 0.98%
IXIC11,127.85+99.11 0.90%

Cybin Gets Review Board Nod to Start Trial in Major Depressive Disorder; Stock Up Over 4% After-Hours

MT Newswires · 06/09/2022 12:58

Please log in to view news